Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus

Virology

Volumn 423, Issue 2, 2012, Pages 119-124

  Gupta, Manisha ^a   MacNeil, Adam ^a   Reed, Zachary D ^a   Rollin, Pierre E ^a   Spiropoulou, Christina F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bundibugyo ebolavirus; Cytokines; Hemorrhagic fever

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BUNDIBUGYO EBOLAVIRUS; BUNDIBUGYO EBOLAVIRUS INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EBOLA VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FILOVIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; VIRUS HEMORRHAGIC FEVER; VIRUS IDENTIFICATION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CYTOKINES; DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; SEROLOGIC TESTS; UGANDA;

EBOLA VIRUS;

EID: 84855777376     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.027     Document Type: Article

References (20)

1. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002, 13:323-340.
2. Baize S., Leroy E.M., Georges-Courbot M.C., Capron M., Lansoud-Soukate J., Debre P., Fisher-Hoch S.P., McCormick J.B., Georges A.J. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 1999, 5:423-426.
3. Baize S., Leroy E.M., Georges A.J., Georges-Courbot M.C., Capron M., Bedjabaga I., Lansoud-Soukate J., Mavoungou E. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 2002, 128:163-168.
4. Brockman M.A., Kwon D.S., Tighe D.P., Pavlik D.F., Rosato P.C., Sela J., Porichis F., Le Gall S., Waring M.T., Moss K., Jessen H., Pereyra F., Kavanagh D.G., Walker B.D., Kaufmann D.E. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009, 114:346-356.
5. Burgner D., Rockett K., Kwiatkowski D. Nitric oxide and infectious diseases. Arch. Dis. Child. 1999, 81:185-188.
6. Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011, 377:849-862.
7. Gupta M., Goldsmith C.S., Metcalfe M.G., Spiropoulou C.F., Rollin P.E. Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus. Virology 2010, 402:203-208.
8. Hutchinson K.L., Rollin P.E. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J. Infect. Dis. 2007, 196(Suppl 2):S357-S363.
9. Ksiazek T.G., Rollin P.E., Williams A.J., Bressler D.S., Martin M.L., Swanepoel R., Burt F.J., Leman P.A., Khan A.S., Rowe A.K., Mukunu R., Sanchez A., Peters C.J. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 1999, 179(Suppl 1):S177-S187.
10. Leroy E.M., Baize S., Volchkov V.E., Fisher-Hoch S.P., Georges-Courbot M.C., Lansoud-Soukate J., Capron M., Debre P., McCormick J.B., Georges A.J. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000, 355:2210-2215.
11. MacNeil A., Farnon E.C., Wamala J., Okware S., Cannon D.L., Reed Z., Towner J.S., Tappero J.W., Lutwama J., Downing R., Nichol S.T., Ksiazek T.G., Rollin P.E. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg. Infect. Dis. 2010, 16:1969-1972.
12. Macneil A., Reed Z., Rollin P.E. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl. Trop. Dis. 2011, 5:e1175.
13. Mahanty S., Kalwar R., Rollin P.E. Cytokine measurement in biological samples after physicochemical treatment for inactivation of biosafety level 4 viral agents. J. Med. Virol. 1999, 59:341-345.
14. Moreira A.P., Dias-Melicio L.A., Soares A.M. Interleukin-10 but not Transforming Growth Factor beta inhibits murine activated macrophages Paracoccidioides brasiliensis killing: effect on H2O2 and NO production. Cell. Immunol. 2010, 263:196-203.
15. O'Garra A., Barrat F.J., Castro A.G., Vicari A., Hawrylowicz C. Strategies for use of IL-10 or its antagonists in human disease. Immunol. Rev. 2008, 223:114-131.
16. Sanchez A., Geisbert T.W., Feldmann H. Fields Virology 2007, 1409-1448. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
17. Smirnova M.G., Kiselev S.L., Gnuchev N.V., Birchall J.P., Pearson J.P. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion. Eur. Cytokine Netw. 2002, 13:161-172.
18. Towner J.S., Sealy T.K., Khristova M.L., Albarino C.G., Conlan S., Reeder S.A., Quan P.L., Lipkin W.I., Downing R., Tappero J.W., Okware S., Lutwama J., Bakamutumaho B., Kayiwa J., Comer J.A., Rollin P.E., Ksiazek T.G., Nichol S.T. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008, 4:e1000212.
19. Villinger F., Rollin P.E., Brar S.S., Chikkala N.F., Winter J., Sundstrom J.B., Zaki S.R., Swanepoel R., Ansari A.A., Peters C.J. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J. Infect. Dis. 1999, 179(Suppl 1):S188-S191.
20. Wauquier N., Becquart P., Padilla C., Baize S., Leroy E.M. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl. Trop. Dis. 2010, 4(10). p11, e837.